Tildrakizumab: interpreting the data. Purvis CG, Emmerich VK, Feldman SR. Br J Dermatol 2021;185:242-243.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Purvis CG, Emmerich VK, Feldman SR. Tildrakizumab: interpreting the data. Br J Dermatol 2021;185:242-243.
PMID: 34031870